Close
ACHEMA MIDDLE EAST 2026

COVID-19 Omicron-Specific Vaccines Could Be Used As Boosters

According to the European Medicines Agency and other international health agencies, coronavirus vaccinations that have been modified to incorporate the omicron variant strain can...

AstraZeneca Cites Early Lung Cancer Immunotherapy Success

The most prevalent kind of the disease, non-small cell lung cancer, has seen steady advancements in immunotherapies called checkpoint inhibitors during the past ten...

Novartis To Slash 8,000 Jobs To Save $1 Billion By 2024

As many as 8,000 employees could be eliminated by Novartis AG as part of a plan to improve the pharmaceutical behemoth's performance and save...

How Lag In African COVID-19 Jabs Slowed Its Once Rapid Pace

The World Health Organization (WHO) set a goal in October 2021 to fully immunise 70% of each nation's population against COVID-19 by the end...

Australia Creates A Novel Stem Cell Production Technique

A novel 3D printed methodology for extracting stem cells from bioreactors has been created by researchers at the University of Technology, Sydney, opening the...

Novartis Promises $250M For Tropical Illnesses, Malaria

Novartis has committed to investing $250 million in research and development over the next five years in an effort to find a cure for...

GSK Commits £1 Billion To Combat Infections In Poor Nations

In order to speed up research and development (R&D) for communicable diseases that disproportionately hurt lower-income nations, GSK plc announced a commitment of £1 billion...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...